Lexraza Developer and Lilly Obesity Chief to Headline Global Clinical Trial Summit in Seoul
What will it take to build on the success of Lexraza, South Korea’s landmark lung cancer drug, and propel it into the next generation of...
Search results for "Cancer"
Global Tobacco Giants Push Nicotine Pouches After FDA Authorizes Reduced-Risk Claims
Multinational tobacco corporations dominating the global market are rapidly shifting focus toward non-combustible alternatives.
Samsung Biologics Slashes Biopharma Development Timeline to 9.5 Months at BioProcess International 2026
Samsung Biologics has unveiled a process innovation case study demonstrating a reduction in biopharmaceutical...
Think All Health Screenings Are Equal? What Happens After the Results Is What Really Counts
"What else should I add to my checkup this year?" It is a question clinicians hear continuously as patients schedule...
Is Abstinence Harmful to Health? What Science Says About Inactivity—and Clergy
Many couples—particularly after middle age—gradually reduce or stop sexual activity altogether, often citing busy...
"Throw These Out Today": Pharmacist Warns Against 5 Common Kitchen Items That Pose Hidden Health Risks
The traditional maxim that frugality is always a virtue does not always apply in the kitchen.
To Curb GLP-1 Misuse, Experts Urge Tracking Who Gets Prescribed Wegovy and Mounjaro—and Why
As the adoption of GLP-1 receptor agonist obesity medications such as Wegovy and Mounjaro accelerates, medical experts...
Metabolic Syndrome Linked to Precancerous Stomach Lesions Independent of H. pylori
Patients who receive clear Helicobacter pylori test results during routine health screenings may still face an elevated...
Cell and Gene Therapy Advances Take Center Stage at Samsung Joint International Symposium
Leading researchers developing stem cell and extracellular vesicle therapies for sepsis, personalized mRNA vaccines for...
GC Pharma’s Homegrown mRNA Vaccine Advances to Phase 2 Trials
GC Pharma announced on the 11th that South Korea’s Ministry of Food and Drug Safety has approved its Phase 2 clinical...